美国FDA药品DMF数据库
(U.S. FDA Drug Master Files)
DMF号码 DMF状态 DMF类型 提交日期 持有人 关联主题/药物名称
42365 A II 2025/08/27 APISYN HEALTHCARE PRIVATE LTD APIXABAN
40839 A II 2025/08/27 MEGAFINE PHARMA P LTD DESVENLAFAXINE SUCCINATE MONOHYDRATE USP (NON-STERILE DRUG SUBSTANCE)
42438 A III 2025/08/26 EAST PHARMA TECHNOLOGIES THREADED METAL CLOSURES AND OTHER METAL COMPONENTS FOR PHARMACEUTICAL PACKAGING
42477 A III 2025/08/26 BASF SE ULTRAFORM® S2320 003 PRO R01 AT UNCOLORED
41804 A II 2025/08/26 YANGZHOU LIBERTY PHARMACEUTICAL CO LTD DOXYCYCLINE HYCLATE (FOR USE IN THE MANUFACTURE OF PARENTERAL PREPARATIONS)
42461 A II 2025/08/25 KREATIVE ORGANICS PRIVATE LTD DICLOFENAC SODIUM USP
40784 A II 2025/08/25 SAI SREYAS PHARMACEUTICALS PVT LTD 4-{4-[(5S)-5-(AMINOMETHYL)-2-OXO-1,3-OXAZOLIDIN-3-YL]PHENYL}MORPHOLIN-3-ONE HYDROCHLORIDE (RVB-3)
42189 A IV 2025/08/23 MUBY CHEM PRIVATE LTD MAGNESIUM CHLORIDE ANHYDROUS USP
42190 A IV 2025/08/23 MUBY CHEM PRIVATE LTD MAGNESIUM ASPARTATE BP
42207 A IV 2025/08/23 MUBY CHEM PRIVATE LTD MALEIC ACID BP
42215 A IV 2025/08/23 MUBY CHEM PRIVATE LTD MAGNESIUM CITRATE (ANHYDROUS) BP
40731 A II 2025/08/23 CHROMO LABORATORIES INDIA PRIVATE LTD POSACONAZOLE
42474 A II 2025/08/23 PRINTTECH HEALTHCARE PVT LTD 5-AMINO-2-HYDROXY BENZOIC ACID (MESALAMINE)
42488 A II 2025/08/23 ENDOC LIFECARE PVT LTD FLUCONAZOLE USP
41889 A II 2025/08/22 LAURUS LABS LTD HYDROCHLOROTHIAZIDE USP
42135 A II 2025/08/22 FUJIAN FUKANG PHARMACEUTICAL CO LTD OSELTAMIVIR PHOSPHATE
42398 A II 2025/08/22 RAKS PHARMA PVT LTD PROPRANOLOL HYDROCHLORIDE USP
42448 A II 2025/08/22 ALLSINO PHARMACEUTICAL CO LTD TIRZEPATIDE SIDE CHAIN FRAGMENT
42273 A III 2025/08/21 HEARTLAND POLYMERS US LLC R7050NA RANDOM COPOLYMER
42274 A III 2025/08/21 HEARTLAND POLYMERS US LLC R7035NA RANDOM COPOLYMER

数据库说明:

当前数据更新日期:2025年10月13日(该库为每季度更新),更多信息请点击此处查询美国FDA药品数据库
©2006-2025 DrugFuture->U.S. FDA Drug Master Files